Author： Mundy G.R.
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.8, Iss.12, 1999-12, pp. : 2009-2015
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Dose calculation of anticancer drugs
By Gao Bo Klumpen Heinz-Josef Gurney Howard
Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 10, 2008-10 ,pp. :
Access to resources
Recommend
Hypoxia-activated anticancer drugs
Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 6, 2005-06 ,pp. :
Advances in the development of hybrid anticancer drugs
Expert Opinion on Drug Discovery, Vol. 8, Iss. 8, 2013-11 ,pp. :
Oral Anticancer Drugs in the Elderly: An Overview
By Lonardi Sara Bortolami Alberto Stefani Micaela Monfardini Silvio
Drugs & Aging, Vol. 24, Iss. 5, 2007-01 ,pp. :